Review





Similar Products

hy p700062af fgf23 mce  (MedChemExpress)
93
MedChemExpress hy p700062af fgf23 mce
Hy P700062af Fgf23 Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hy p700062af fgf23 mce/product/MedChemExpress
Average 93 stars, based on 1 article reviews
hy p700062af fgf23 mce - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
elisa kits  (Cusabio)
93
Cusabio elisa kits
Elisa Kits, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa kits/product/Cusabio
Average 93 stars, based on 1 article reviews
elisa kits - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
fgf23 concentrations  (Cusabio)
93
Cusabio fgf23 concentrations
Fgf23 Concentrations, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fgf23 concentrations/product/Cusabio
Average 93 stars, based on 1 article reviews
fgf23 concentrations - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
mouse fgf23 elisa kit  (Cusabio)
91
Cusabio mouse fgf23 elisa kit
Transcriptomic analysis of femoral tissues from sham, OVX, and OVX + GLP-2 groups. A Scatter plot of DEGs between the OVX and sham groups (1654 upregulated genes and 2038 downregulated genes). B Scatter plot of DEGs between the OVX + GLP-2 and OVX groups (318 upregulated genes and 396 downregulated genes). C Heatmap of 24 representative DEGs among the three groups. D GO enrichmentresults showing DEGs involved in cellular component, biological process, and molecular function categories. E KEGG signalling pathway diagram. F KEGG enrichment bar chart. G KEGG enrichment scatter plot. H Relative mRNA expression of <t>FGF23,</t> FGF6, and FGF18 in the tibiae of the OVX group
Mouse Fgf23 Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse fgf23 elisa kit/product/Cusabio
Average 91 stars, based on 1 article reviews
mouse fgf23 elisa kit - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier
fgf23 levels  (Cusabio)
93
Cusabio fgf23 levels
Transcriptomic analysis of femoral tissues from sham, OVX, and OVX + GLP-2 groups. A Scatter plot of DEGs between the OVX and sham groups (1654 upregulated genes and 2038 downregulated genes). B Scatter plot of DEGs between the OVX + GLP-2 and OVX groups (318 upregulated genes and 396 downregulated genes). C Heatmap of 24 representative DEGs among the three groups. D GO enrichmentresults showing DEGs involved in cellular component, biological process, and molecular function categories. E KEGG signalling pathway diagram. F KEGG enrichment bar chart. G KEGG enrichment scatter plot. H Relative mRNA expression of <t>FGF23,</t> FGF6, and FGF18 in the tibiae of the OVX group
Fgf23 Levels, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fgf23 levels/product/Cusabio
Average 93 stars, based on 1 article reviews
fgf23 levels - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
human fgf23 elisa kit  (Biorbyt)
93
Biorbyt human fgf23 elisa kit
Transcriptomic analysis of femoral tissues from sham, OVX, and OVX + GLP-2 groups. A Scatter plot of DEGs between the OVX and sham groups (1654 upregulated genes and 2038 downregulated genes). B Scatter plot of DEGs between the OVX + GLP-2 and OVX groups (318 upregulated genes and 396 downregulated genes). C Heatmap of 24 representative DEGs among the three groups. D GO enrichmentresults showing DEGs involved in cellular component, biological process, and molecular function categories. E KEGG signalling pathway diagram. F KEGG enrichment bar chart. G KEGG enrichment scatter plot. H Relative mRNA expression of <t>FGF23,</t> FGF6, and FGF18 in the tibiae of the OVX group
Human Fgf23 Elisa Kit, supplied by Biorbyt, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human fgf23 elisa kit/product/Biorbyt
Average 93 stars, based on 1 article reviews
human fgf23 elisa kit - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

Image Search Results


Transcriptomic analysis of femoral tissues from sham, OVX, and OVX + GLP-2 groups. A Scatter plot of DEGs between the OVX and sham groups (1654 upregulated genes and 2038 downregulated genes). B Scatter plot of DEGs between the OVX + GLP-2 and OVX groups (318 upregulated genes and 396 downregulated genes). C Heatmap of 24 representative DEGs among the three groups. D GO enrichmentresults showing DEGs involved in cellular component, biological process, and molecular function categories. E KEGG signalling pathway diagram. F KEGG enrichment bar chart. G KEGG enrichment scatter plot. H Relative mRNA expression of FGF23, FGF6, and FGF18 in the tibiae of the OVX group

Journal: Journal of Orthopaedic Surgery and Research

Article Title: GLP-2 alleviates postmenopausal osteoporosis by acting on osteoblasts through the PI3K/AKT/FOXO1 signalling pathway to downregulate FGF23 expression

doi: 10.1186/s13018-026-06661-2

Figure Lengend Snippet: Transcriptomic analysis of femoral tissues from sham, OVX, and OVX + GLP-2 groups. A Scatter plot of DEGs between the OVX and sham groups (1654 upregulated genes and 2038 downregulated genes). B Scatter plot of DEGs between the OVX + GLP-2 and OVX groups (318 upregulated genes and 396 downregulated genes). C Heatmap of 24 representative DEGs among the three groups. D GO enrichmentresults showing DEGs involved in cellular component, biological process, and molecular function categories. E KEGG signalling pathway diagram. F KEGG enrichment bar chart. G KEGG enrichment scatter plot. H Relative mRNA expression of FGF23, FGF6, and FGF18 in the tibiae of the OVX group

Article Snippet: FGF23 levels in cell culture supernatants were measured using a mouse FGF23 ELISA Kit (CSB-EL008629MO, Cusabio) following the manufacturer’s protocol.

Techniques: Expressing

Effects of GLP-2 and the PI3K inhibitor LY294002 on FGF23 expression in OVX mice. Forty-four female C57BL/6J mice were randomly divided into five groups: sham-operated (sham, n = 6), OVX treated with vehicle (OVX, n = 8), OVX treated with GLP-2 (OVX + GLP-2, n = 10), OVX treated with LY294002 (OVX + LY294002, n = 10), and OVX treated with GLP-2 plus LY294002 (OVX + GLP-2 + LY294002, n = 10). A IHC staining of FGF23 in the distal femur and corresponding MOD analysis. B Relative mRNA expression of FGF23 in femurs. C Serum FGF23 levels measured by ELISA. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Journal: Journal of Orthopaedic Surgery and Research

Article Title: GLP-2 alleviates postmenopausal osteoporosis by acting on osteoblasts through the PI3K/AKT/FOXO1 signalling pathway to downregulate FGF23 expression

doi: 10.1186/s13018-026-06661-2

Figure Lengend Snippet: Effects of GLP-2 and the PI3K inhibitor LY294002 on FGF23 expression in OVX mice. Forty-four female C57BL/6J mice were randomly divided into five groups: sham-operated (sham, n = 6), OVX treated with vehicle (OVX, n = 8), OVX treated with GLP-2 (OVX + GLP-2, n = 10), OVX treated with LY294002 (OVX + LY294002, n = 10), and OVX treated with GLP-2 plus LY294002 (OVX + GLP-2 + LY294002, n = 10). A IHC staining of FGF23 in the distal femur and corresponding MOD analysis. B Relative mRNA expression of FGF23 in femurs. C Serum FGF23 levels measured by ELISA. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Article Snippet: FGF23 levels in cell culture supernatants were measured using a mouse FGF23 ELISA Kit (CSB-EL008629MO, Cusabio) following the manufacturer’s protocol.

Techniques: Expressing, Immunohistochemistry, Enzyme-linked Immunosorbent Assay

GLP-2 downregulates FGF23 expression by activating GLP-2R/PI3K/AKT signalling in osteoblasts. A Western blot analysis of AKT and p-AKT levels in osteoblasts with or without shRNA-GLP-2R interference. B Relative mRNA expression of FGF23 in osteoblasts treated with or without shRNA-GLP-2R. C Western blot analysis of AKT and p-AKT levels in cells treated with or without LY294002. D Relative mRNA expression of FGF23 following LY294002 intervention. E Western blot analysis of AKT and p-AKT levels in cells treated with or without MK-2206. F Relative mRNA expression of FGF23 after MK-2206 treatment. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Journal: Journal of Orthopaedic Surgery and Research

Article Title: GLP-2 alleviates postmenopausal osteoporosis by acting on osteoblasts through the PI3K/AKT/FOXO1 signalling pathway to downregulate FGF23 expression

doi: 10.1186/s13018-026-06661-2

Figure Lengend Snippet: GLP-2 downregulates FGF23 expression by activating GLP-2R/PI3K/AKT signalling in osteoblasts. A Western blot analysis of AKT and p-AKT levels in osteoblasts with or without shRNA-GLP-2R interference. B Relative mRNA expression of FGF23 in osteoblasts treated with or without shRNA-GLP-2R. C Western blot analysis of AKT and p-AKT levels in cells treated with or without LY294002. D Relative mRNA expression of FGF23 following LY294002 intervention. E Western blot analysis of AKT and p-AKT levels in cells treated with or without MK-2206. F Relative mRNA expression of FGF23 after MK-2206 treatment. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Article Snippet: FGF23 levels in cell culture supernatants were measured using a mouse FGF23 ELISA Kit (CSB-EL008629MO, Cusabio) following the manufacturer’s protocol.

Techniques: Expressing, Western Blot, shRNA

GLP-2 regulates FGF23 expression via the inactivation of FOXO1. A Western blot analysis of FOXO1 and p-FOXO1 levels in osteoblasts treated with or without GLP-2. B Immunofluorescence staining of FOXO1 in osteoblasts (green), counterstained with DAPI (blue). C Relative mRNA expression of FGF23 in osteoblasts treated with the FOXO1 inhibitor AS1842856. D Verification of FOXO1 overexpression by Western blot after PCDH-FOXO1 transfection. E Effect of FOXO1 overexpression on FGF23 mRNA levels in osteoblasts with or without GLP-2 treatment. F Effect of FOXO1 overexpression on the FGF23 concentration in the cell culture supernatant. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Journal: Journal of Orthopaedic Surgery and Research

Article Title: GLP-2 alleviates postmenopausal osteoporosis by acting on osteoblasts through the PI3K/AKT/FOXO1 signalling pathway to downregulate FGF23 expression

doi: 10.1186/s13018-026-06661-2

Figure Lengend Snippet: GLP-2 regulates FGF23 expression via the inactivation of FOXO1. A Western blot analysis of FOXO1 and p-FOXO1 levels in osteoblasts treated with or without GLP-2. B Immunofluorescence staining of FOXO1 in osteoblasts (green), counterstained with DAPI (blue). C Relative mRNA expression of FGF23 in osteoblasts treated with the FOXO1 inhibitor AS1842856. D Verification of FOXO1 overexpression by Western blot after PCDH-FOXO1 transfection. E Effect of FOXO1 overexpression on FGF23 mRNA levels in osteoblasts with or without GLP-2 treatment. F Effect of FOXO1 overexpression on the FGF23 concentration in the cell culture supernatant. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Article Snippet: FGF23 levels in cell culture supernatants were measured using a mouse FGF23 ELISA Kit (CSB-EL008629MO, Cusabio) following the manufacturer’s protocol.

Techniques: Expressing, Western Blot, Immunofluorescence, Staining, Over Expression, Transfection, Concentration Assay, Cell Culture

Mechanistic diagram illustrating how GLP-2 downregulates FGF23 to ameliorate postmenopausal osteoporosis via the GLP-2R/PI3K/AKT/FOXO1 signalling pathway

Journal: Journal of Orthopaedic Surgery and Research

Article Title: GLP-2 alleviates postmenopausal osteoporosis by acting on osteoblasts through the PI3K/AKT/FOXO1 signalling pathway to downregulate FGF23 expression

doi: 10.1186/s13018-026-06661-2

Figure Lengend Snippet: Mechanistic diagram illustrating how GLP-2 downregulates FGF23 to ameliorate postmenopausal osteoporosis via the GLP-2R/PI3K/AKT/FOXO1 signalling pathway

Article Snippet: FGF23 levels in cell culture supernatants were measured using a mouse FGF23 ELISA Kit (CSB-EL008629MO, Cusabio) following the manufacturer’s protocol.

Techniques:

Transcriptomic analysis of femoral tissues from sham, OVX, and OVX + GLP-2 groups. A Scatter plot of DEGs between the OVX and sham groups (1654 upregulated genes and 2038 downregulated genes). B Scatter plot of DEGs between the OVX + GLP-2 and OVX groups (318 upregulated genes and 396 downregulated genes). C Heatmap of 24 representative DEGs among the three groups. D GO enrichmentresults showing DEGs involved in cellular component, biological process, and molecular function categories. E KEGG signalling pathway diagram. F KEGG enrichment bar chart. G KEGG enrichment scatter plot. H Relative mRNA expression of FGF23, FGF6, and FGF18 in the tibiae of the OVX group

Journal: Journal of Orthopaedic Surgery and Research

Article Title: GLP-2 alleviates postmenopausal osteoporosis by acting on osteoblasts through the PI3K/AKT/FOXO1 signalling pathway to downregulate FGF23 expression

doi: 10.1186/s13018-026-06661-2

Figure Lengend Snippet: Transcriptomic analysis of femoral tissues from sham, OVX, and OVX + GLP-2 groups. A Scatter plot of DEGs between the OVX and sham groups (1654 upregulated genes and 2038 downregulated genes). B Scatter plot of DEGs between the OVX + GLP-2 and OVX groups (318 upregulated genes and 396 downregulated genes). C Heatmap of 24 representative DEGs among the three groups. D GO enrichmentresults showing DEGs involved in cellular component, biological process, and molecular function categories. E KEGG signalling pathway diagram. F KEGG enrichment bar chart. G KEGG enrichment scatter plot. H Relative mRNA expression of FGF23, FGF6, and FGF18 in the tibiae of the OVX group

Article Snippet: FGF23 levels in cell culture supernatants were measured using a mouse FGF23 ELISA Kit (CSB-EL008629MO, Cusabio) following the manufacturer’s protocol.

Techniques: Expressing

Effects of GLP-2 and the PI3K inhibitor LY294002 on FGF23 expression in OVX mice. Forty-four female C57BL/6J mice were randomly divided into five groups: sham-operated (sham, n = 6), OVX treated with vehicle (OVX, n = 8), OVX treated with GLP-2 (OVX + GLP-2, n = 10), OVX treated with LY294002 (OVX + LY294002, n = 10), and OVX treated with GLP-2 plus LY294002 (OVX + GLP-2 + LY294002, n = 10). A IHC staining of FGF23 in the distal femur and corresponding MOD analysis. B Relative mRNA expression of FGF23 in femurs. C Serum FGF23 levels measured by ELISA. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Journal: Journal of Orthopaedic Surgery and Research

Article Title: GLP-2 alleviates postmenopausal osteoporosis by acting on osteoblasts through the PI3K/AKT/FOXO1 signalling pathway to downregulate FGF23 expression

doi: 10.1186/s13018-026-06661-2

Figure Lengend Snippet: Effects of GLP-2 and the PI3K inhibitor LY294002 on FGF23 expression in OVX mice. Forty-four female C57BL/6J mice were randomly divided into five groups: sham-operated (sham, n = 6), OVX treated with vehicle (OVX, n = 8), OVX treated with GLP-2 (OVX + GLP-2, n = 10), OVX treated with LY294002 (OVX + LY294002, n = 10), and OVX treated with GLP-2 plus LY294002 (OVX + GLP-2 + LY294002, n = 10). A IHC staining of FGF23 in the distal femur and corresponding MOD analysis. B Relative mRNA expression of FGF23 in femurs. C Serum FGF23 levels measured by ELISA. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Article Snippet: FGF23 levels in cell culture supernatants were measured using a mouse FGF23 ELISA Kit (CSB-EL008629MO, Cusabio) following the manufacturer’s protocol.

Techniques: Expressing, Immunohistochemistry, Enzyme-linked Immunosorbent Assay

GLP-2 downregulates FGF23 expression by activating GLP-2R/PI3K/AKT signalling in osteoblasts. A Western blot analysis of AKT and p-AKT levels in osteoblasts with or without shRNA-GLP-2R interference. B Relative mRNA expression of FGF23 in osteoblasts treated with or without shRNA-GLP-2R. C Western blot analysis of AKT and p-AKT levels in cells treated with or without LY294002. D Relative mRNA expression of FGF23 following LY294002 intervention. E Western blot analysis of AKT and p-AKT levels in cells treated with or without MK-2206. F Relative mRNA expression of FGF23 after MK-2206 treatment. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Journal: Journal of Orthopaedic Surgery and Research

Article Title: GLP-2 alleviates postmenopausal osteoporosis by acting on osteoblasts through the PI3K/AKT/FOXO1 signalling pathway to downregulate FGF23 expression

doi: 10.1186/s13018-026-06661-2

Figure Lengend Snippet: GLP-2 downregulates FGF23 expression by activating GLP-2R/PI3K/AKT signalling in osteoblasts. A Western blot analysis of AKT and p-AKT levels in osteoblasts with or without shRNA-GLP-2R interference. B Relative mRNA expression of FGF23 in osteoblasts treated with or without shRNA-GLP-2R. C Western blot analysis of AKT and p-AKT levels in cells treated with or without LY294002. D Relative mRNA expression of FGF23 following LY294002 intervention. E Western blot analysis of AKT and p-AKT levels in cells treated with or without MK-2206. F Relative mRNA expression of FGF23 after MK-2206 treatment. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Article Snippet: FGF23 levels in cell culture supernatants were measured using a mouse FGF23 ELISA Kit (CSB-EL008629MO, Cusabio) following the manufacturer’s protocol.

Techniques: Expressing, Western Blot, shRNA

GLP-2 regulates FGF23 expression via the inactivation of FOXO1. A Western blot analysis of FOXO1 and p-FOXO1 levels in osteoblasts treated with or without GLP-2. B Immunofluorescence staining of FOXO1 in osteoblasts (green), counterstained with DAPI (blue). C Relative mRNA expression of FGF23 in osteoblasts treated with the FOXO1 inhibitor AS1842856. D Verification of FOXO1 overexpression by Western blot after PCDH-FOXO1 transfection. E Effect of FOXO1 overexpression on FGF23 mRNA levels in osteoblasts with or without GLP-2 treatment. F Effect of FOXO1 overexpression on the FGF23 concentration in the cell culture supernatant. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Journal: Journal of Orthopaedic Surgery and Research

Article Title: GLP-2 alleviates postmenopausal osteoporosis by acting on osteoblasts through the PI3K/AKT/FOXO1 signalling pathway to downregulate FGF23 expression

doi: 10.1186/s13018-026-06661-2

Figure Lengend Snippet: GLP-2 regulates FGF23 expression via the inactivation of FOXO1. A Western blot analysis of FOXO1 and p-FOXO1 levels in osteoblasts treated with or without GLP-2. B Immunofluorescence staining of FOXO1 in osteoblasts (green), counterstained with DAPI (blue). C Relative mRNA expression of FGF23 in osteoblasts treated with the FOXO1 inhibitor AS1842856. D Verification of FOXO1 overexpression by Western blot after PCDH-FOXO1 transfection. E Effect of FOXO1 overexpression on FGF23 mRNA levels in osteoblasts with or without GLP-2 treatment. F Effect of FOXO1 overexpression on the FGF23 concentration in the cell culture supernatant. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Article Snippet: FGF23 levels in cell culture supernatants were measured using a mouse FGF23 ELISA Kit (CSB-EL008629MO, Cusabio) following the manufacturer’s protocol.

Techniques: Expressing, Western Blot, Immunofluorescence, Staining, Over Expression, Transfection, Concentration Assay, Cell Culture

Mechanistic diagram illustrating how GLP-2 downregulates FGF23 to ameliorate postmenopausal osteoporosis via the GLP-2R/PI3K/AKT/FOXO1 signalling pathway

Journal: Journal of Orthopaedic Surgery and Research

Article Title: GLP-2 alleviates postmenopausal osteoporosis by acting on osteoblasts through the PI3K/AKT/FOXO1 signalling pathway to downregulate FGF23 expression

doi: 10.1186/s13018-026-06661-2

Figure Lengend Snippet: Mechanistic diagram illustrating how GLP-2 downregulates FGF23 to ameliorate postmenopausal osteoporosis via the GLP-2R/PI3K/AKT/FOXO1 signalling pathway

Article Snippet: FGF23 levels in cell culture supernatants were measured using a mouse FGF23 ELISA Kit (CSB-EL008629MO, Cusabio) following the manufacturer’s protocol.

Techniques: